Complete Filing Data
Terra Innovatum Global N.V. — complete XBRL filing history below.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Terra Innovatum Global N.V. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|
| Net Income Loss | -$3.0M | -$1.1M | -$1.4M | $16.0K | $20.0K |
| Research And Development Expense | $155.0K | $16.0K | |||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$49.0K | $27.0K | |||
| Operating Income Loss | -$2.3M | -$18.0K | |||
| Operating Expenses | $2.3M | $18.0K | |||
| Nonoperating Income Expense | -$697.0K | $34.0K | |||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$3.0M | $16.0K | |||
| Comprehensive Income Net Of Tax | -$3.0M | $43.0K | |||
| Selling General And Administrative Expense | $2.1M | $2.0K | |||
| Other Nonoperating Expense | $160.0K | ||||
| Interest Expense Nonoperating | $537.0K |
Balance Sheet
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$4.2M | -$1.5M | -$1.5M | -$32.0K | $64.0K | $19.0K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $2.2M | $69.0K | $14.0K | $2.0K | |||
| Retained Earnings Accumulated Deficit | -$5.6M | -$37.0K | |||||
| Prepaid Expense And Other Assets Current | $385.0K | $65.0K | |||||
| Other Liabilities Noncurrent | $167.0K | $6.0K | |||||
| Long Term Loans Payable | $325.0K | $107.0K | |||||
| Liabilities Current | $7.5M | $53.0K | |||||
| Liabilities And Stockholders Equity | $3.7M | $134.0K | |||||
| Liabilities | $8.0M | $166.0K | |||||
| Cash And Cash Equivalents At Carrying Value | $2.2M | $69.0K | |||||
| Assets Current | $3.7M | $134.0K | |||||
| Assets | $3.7M | $134.0K | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$30.0K | $2.0K | |||||
| Accounts Payable Current | $3.7M | $32.0K | |||||
| Accounts Payable And Other Accrued Liabilities Current | $221.0K | $21.0K | |||||
| Property Plant And Equipment Net | $98.0K | ||||||
| Other Loans Payable Current | $3.6M | ||||||
| Deferred Costs Current | $1.1M |
Other Metrics
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Stock Issued During Period Value Foreign Currency Translation | -$49.0K | $11.0K | $6.0K | $29.0K | -$1.0K | |
| Fair Value Adjustment Of Warrants | $1.3M | |||||
| Corporate Capital | $15.0K | $3.0K | ||||
| Capital Contributions | $12.0K | |||||
| Adjustments To Additional Paid In Capital Warrant Issued | $1.1M | |||||
| Additional Paid In Capital | $1.4M | |||||
| Stock Issued During Period Value Issuance Of Bridge Loans Net | $325.0K |
Data sourced from SEC EDGAR public filings as of August 5, 2026.